bacteriophage phi x174
Biologicalexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 1995 (NCT01617122)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- BacteriophageOTHER
Bacteriophage other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bacteriophage ox174
- bacteriophage phi x174
- bacteriophage phi x 174
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00006066 | Phase 1 | Jul 14, 2000 | National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) |
| NCT01617122 | N/A | Oct 1, 1995 | University of South Florida |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2000 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2000 |
| University of South Florida | Academic/Hospital | 1 | 1 | 1 | 1995 |
3 organizations
Page 1 / 1